IMiDs uniquely synergize with TKIs to upregulate apoptosis of Philadelphia chromosome-positive acute lymphoblastic leukemia cells expressing a dominant-negative IKZF1 isoform
Abstract The long-term prognosis of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) is still unsatisfactory even after the emergence of tyrosine kinase inhibitors (TKIs) against chimeric BCR-ABL, and this is associated with the high incidence of genetic alterations of Ikaros...
Main Authors: | Daisuke Harama, Takashi Yahata, Keiko Kagami, Masako Abe, Norie Ando, Shin Kasai, Minori Tamai, Koshi Akahane, Takeshi Inukai, Nobutaka Kiyokawa, Abd Aziz Ibrahim, Kiyoshi Ando, Kanji Sugita |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-06-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-021-00523-y |
Similar Items
-
Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
by: Yoo Jin Jung, et al.
Published: (2021-03-01) -
The effects of IMiDs immunomodulatory drugs on human regulatory T cells
by: Meyer, Brendan
Published: (2011) -
Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide
by: Hirotake Furihata, et al.
Published: (2020-09-01) -
Pharmacokinetics and P-glycoprotein-Mediated Transport of the Leading IMiDs in Mice
by: Rozewski, Darlene M.
Published: (2012) -
Immunomodulatory drugs (IMiDs) in multiple myeloma: mechanism of action and clinical implications
by: Xu, Mengni
Published: (2017)